retatrutide phase 2 trial results obesity VisualAbstract: reduces body weight by 17.5% in patients with Effects of retatrutide on body

Bwire GM

*Correspondence: Cunshui Xue, [email protected]

Br J Pharmacol 179(4):659676 Hernandez AF, Green JB, Janmohamed S, DAgostino Sr RB, Granger CB, Jones NP, et al (2018) Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial

Better Cholesterol Profiles: These medications can improve lipid profiles, leading to lower levels of bad cholesterol and triglycerides

402,403,404 Adipose tissue hypoxia and inflammation may lead to adipocyte dysfunction and obesity-induced insulin resistance in HFD-fed models, as indicated by increased infiltration of adipose tissue macrophages (ATMs), activation of the NLRP3 inflammasome and increased levels of proinflammatory cytokines

One study found increased oxygen uptake in muscle tissue even when availability was lower